Neuroischemic diabetic foot syndrome in patients with chronic kidney disease is associated with severe peripheral arterial disease, impaired tissue repair, recurrent infectious complications, and high risk of major amputation. Although revascularization remains a cornerstone of limb salvage strategies, the effectiveness of conventional treatment approaches may be substantially limited in patients with advanced renal dysfunction because of restricted feasibility of contrast-enhanced vascular imaging and endovascular correction. To evaluate the effectiveness and limitations of conventional treatment strategies in patients with neuroischemic diabetic foot syndrome and chronic kidney disease depending on the severity of renal dysfunction. This retrospective study included 55 patients with neuroischemic diabetic foot syndrome and chronic kidney disease. Patients were divided into two groups according to renal function severity: Group I included 34 patients with compensated chronic kidney disease (G1-G3a, eGFR ≥45 ml/min/1.73 m²), whereas Group II consisted of 21 patients with decompensated chronic kidney disease (G3b-G5, eGFR <45 ml/min/1.73 m²). Clinical, metabolic, laboratory, vascular, surgical, and postoperative outcomes were analyzed comparatively. Special attention was paid to feasibility of vascular imaging, endovascular treatment, limb preservation, repeated surgical interventions, and mortality. Patients with advanced chronic kidney disease demonstrated more severe ischemic and infectious lesions, higher prevalence of gangrene, larger wound defects, elevated inflammatory markers, anemia, and hypoalbuminemia. Computed tomography angiography was performed significantly less frequently in Group II (28.6% vs 58.8%), while endovascular revascularization procedures were markedly restricted in patients with severe renal dysfunction. Post-angiographic deterioration of renal function occurred in 23.8% of Group II patients compared with 5.9% in Group I. Patients with decompensated chronic kidney disease demonstrated substantially higher rates of repeated surgical procedures, major amputations, reamputations, recurrent necrotic complications, and six-month mortality. Functional limb preservation was achieved in 82.4% of patients in Group I and only 42.9% in Group II. No patients with advanced chronic kidney disease achieved stable long-term “good” treatment outcome. Advanced chronic kidney disease significantly limits the effectiveness of conventional treatment strategies in patients with neuroischemic diabetic foot syndrome. Restricted feasibility of contrast-enhanced vascular imaging and endovascular correction, combined with severe metabolic and inflammatory disturbances, substantially worsens limb salvage outcomes and increases the risk of major amputation and mortality. Development of individualized treatment approaches with reduced nephrotoxic exposure may improve outcomes in this high-risk patient population.

Neuroischemic diabetic foot syndrome, chronic kidney disease, peripheral arterial disease

Armstrong D.G., Swerdlow M.A., Armstrong A.A., Conte M.S., Padula W.V., Bus S.A. Five-year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer // Journal of Foot and Ankle Research. 2020. Vol. 13, No. 1. Article ID 16.

McDermott K., Fang M., Boulton A.J.M., Selvin E., Hicks C.W. Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers // Diabetes Care. 2023. Vol. 46, No. 1. P. 209-221.

Prompers L., Huijberts M., Apelqvist J., et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe: baseline results from the Eurodiale study // Diabetologia. 2007. Vol. 50, No. 1. P. 18-25.

Hingorani A., LaMuraglia G.M., Henke P., et al. The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine // Journal of Vascular Surgery. 2016. Vol. 63. P. 3S-21S.

International Working Group on the Diabetic Foot. IWGDF Guidelines on the prevention and management of diabetic foot disease. The Netherlands: IWGDF, 2023. 112 p.

European Society of Cardiology (ESC), European Society for Vascular Surgery (ESVS). ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases // European Heart Journal. 2017. Vol. 39, No. 9. P. 763-816.

Noronen K., Saarinen E., Albäck A., Venermo M. Analysis of the elective treatment process for critical limb ischaemia with tissue loss: diabetic patients require rapid revascularisation // European Journal of Vascular and Endovascular Surgery. 2017. Vol. 53, No. 2. P. 206-213.

Fujihara M., Kawasaki D., Shintani Y., et al. Safety and feasibility of carbon dioxide angiography during endovascular therapy for patients with chronic kidney disease // Cardiovascular Intervention and Therapeutics. 2017. Vol. 32, No. 4. P. 315-320.

Gualtieri G., Santoro D., Spinelli F., Mallamaci F., Tripepi G., Zoccali C. Carbon dioxide angiography in patients with critical limb ischemia and advanced chronic kidney disease: safety and efficacy // Journal of Cardiovascular Medicine. 2019. Vol. 20, No. 4. P. 282-289.

Jiang Y., Ran X., Jia L., et al. Epidemiology of type 2 diabetic foot problems and predictive factors for amputation in China // International Journal of Lower Extremity Wounds. 2015. Vol. 14. P. 19-27.

Kessel D.O., Patel J.V., Robertson I., et al. Carbon dioxide as a contrast agent in peripheral angiography: current status // European Radiology. 2003. Vol. 13, No. 5. P. 1135-1147.

Liu Z., Dumville J.C., Hinchliffe R.J., et al. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus // Cochrane Database of Systematic Reviews. 2018. Vol. 10. Article ID CD010318.

Monteiro-Soares M., Hamilton E.J., Russell D.A., et al. Classification of foot ulcers in people with diabetes: a systematic review // Diabetes/Metabolism Research and Reviews. Published online: 02.05.2023.

Ragnarson Tennvall G., Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers // Journal of Diabetes and its Complications. 2000. Vol. 14, No. 5. P. 235-241.

Van Netten J.J., Price P.E., Lavery L.A., et al. Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review // Diabetes/Metabolism Research and Reviews. 2016. Vol. 32, Suppl. 1. P. 84-98.

Woelfel S., Shin L., Armstrong D.G. Wound care // In: Sidawy M.D.A., Perler M.D.B., eds. Rutherford’s Vascular Surgery and Endovascular Therapy. 10th ed. Elsevier, 2022.

Zeng Z., Dong Y., Hua Q., et al. Computed tomography perfusion study evaluating the curative effect of tibial transverse transport in patients with severe diabetic foot // Journal of Orthopaedic Translation. 2019. Vol. 4. P. 5-14.